Novartis AG 2008 AR2
The report outlines the company's financial and corporate citizenship performance for the fiscal year 2008. Novartis achieved record net sales of USD 41.5 billion from continuing operations, driven by strong performance in its Pharmaceuticals division and recently launched products. In corporate citizenship, the company delivered treatments worth USD 1.26 billion through access-to-medicine programs, reaching 74 million patients in need. Additionally, Novartis reduced its Scope 1 greenhouse gas emissions to 404 kilotons and improved its lost-time injury and illness rate to 0.34.
Company: Novartis AG
Sector: Manufacturing
Country: Switzerland
Year: 2008
Type: AR2
Pages: 260
Back to company
Novartis AG
Annual Report
The report outlines the company's financial and corporate citizenship performance for the fiscal year 2008. Novartis achieved record net sales of USD 41.5 billion from continuing operations, driven by strong performance in its Pharmaceuticals division and recently launched products. In corporate citizenship, the company delivered treatments worth USD 1.26 billion through access-to-medicine programs, reaching 74 million patients in need. Additionally, Novartis reduced its Scope 1 greenhouse gas emissions to 404 kilotons and improved its lost-time injury and illness rate to 0.34.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2008
Reporting Period
Jan 1, 2008 - Dec 31, 2008
Fiscal Year
2008
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Women in Management
Workplace Fatalities
Employees